Eintrag weiter verarbeiten
Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression
Gespeichert in:
| Zeitschriftentitel: | International Journal of Cancer |
|---|---|
| Personen und Körperschaften: | , , , , , , , , |
| In: | International Journal of Cancer, 145, 2019, 8, S. 2267-2281 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Arroyo‐Crespo, Juan J. Armiñán, Ana Charbonnier, David Deladriere, Coralie Palomino‐Schätzlein, Martina Lamas‐Domingo, Rubén Forteza, Jerónimo Pineda‐Lucena, Antonio Vicent, María J. Arroyo‐Crespo, Juan J. Armiñán, Ana Charbonnier, David Deladriere, Coralie Palomino‐Schätzlein, Martina Lamas‐Domingo, Rubén Forteza, Jerónimo Pineda‐Lucena, Antonio Vicent, María J. |
|---|---|
| author |
Arroyo‐Crespo, Juan J. Armiñán, Ana Charbonnier, David Deladriere, Coralie Palomino‐Schätzlein, Martina Lamas‐Domingo, Rubén Forteza, Jerónimo Pineda‐Lucena, Antonio Vicent, María J. |
| spellingShingle |
Arroyo‐Crespo, Juan J. Armiñán, Ana Charbonnier, David Deladriere, Coralie Palomino‐Schätzlein, Martina Lamas‐Domingo, Rubén Forteza, Jerónimo Pineda‐Lucena, Antonio Vicent, María J. International Journal of Cancer Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression Cancer Research Oncology |
| author_sort |
arroyo‐crespo, juan j. |
| spelling |
Arroyo‐Crespo, Juan J. Armiñán, Ana Charbonnier, David Deladriere, Coralie Palomino‐Schätzlein, Martina Lamas‐Domingo, Rubén Forteza, Jerónimo Pineda‐Lucena, Antonio Vicent, María J. 0020-7136 1097-0215 Wiley Cancer Research Oncology http://dx.doi.org/10.1002/ijc.32270 <jats:p>Triple‐negative breast cancer (TNBC), an aggressive, metastatic and recurrent breast cancer (BC) subtype, currently suffers from a lack of adequately described spontaneously metastatic preclinical models that faithfully reproduce the clinical scenario. We describe two preclinical spontaneously metastatic TNBC orthotopic murine models for the development of advanced therapeutics: an immunodeficient human MDA‐MB‐231‐Luc model and an immunocompetent mouse 4T1 model. Furthermore, we provide a broad range of multifactorial analysis for both models that could provide relevant information for the development of new therapies and diagnostic tools. Our comparisons uncovered differential growth rates, stromal arrangements and metabolic profiles in primary tumors, and the presence of cancer‐associated adipocyte infiltration in the MDA‐MB‐231‐Luc model. Histopathological studies highlighted the more rapid metastatic spread to the lungs in the 4T1 model following a lymphatic route, while we observed both homogeneous (MDA‐MB‐231‐Luc) and heterogeneous (4T1) metastatic spread to axillary lymph nodes. We encountered unique metabolomic signatures in each model, including crucial amino acids and cell membrane components. Hematological analysis demonstrated severe leukemoid and lymphoid reactions in the 4T1 model with the partial reestablishment of immune responses in the immunocompromised MDA‐MB‐231‐Luc model. Additionally, we discovered β‐immunoglobulinemia and increased basal levels of G‐CSF correlating with a metastatic switch, with G‐CSF also promoting extramedullary hematopoiesis (both models) and causing hepatosplenomegaly (4T1 model). Overall, we believe that the characterization of these preclinical models will foster the development of advanced therapeutic strategies for TNBC treatment, especially for the treatment of patients presenting both, primary tumors and metastatic spread.</jats:p> Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression International Journal of Cancer |
| doi_str_mv |
10.1002/ijc.32270 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9pamMuMzIyNzA |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9pamMuMzIyNzA |
| institution |
DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 |
| imprint |
Wiley, 2019 |
| imprint_str_mv |
Wiley, 2019 |
| issn |
0020-7136 1097-0215 |
| issn_str_mv |
0020-7136 1097-0215 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
arroyocrespo2019characterizationoftriplenegativebreastcancerpreclinicalmodelsprovidesfunctionalevidenceofmetastaticprogression |
| publishDateSort |
2019 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
International Journal of Cancer |
| source_id |
49 |
| title |
Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression |
| title_unstemmed |
Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression |
| title_full |
Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression |
| title_fullStr |
Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression |
| title_full_unstemmed |
Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression |
| title_short |
Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression |
| title_sort |
characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression |
| topic |
Cancer Research Oncology |
| url |
http://dx.doi.org/10.1002/ijc.32270 |
| publishDate |
2019 |
| physical |
2267-2281 |
| description |
<jats:p>Triple‐negative breast cancer (TNBC), an aggressive, metastatic and recurrent breast cancer (BC) subtype, currently suffers from a lack of adequately described spontaneously metastatic preclinical models that faithfully reproduce the clinical scenario. We describe two preclinical spontaneously metastatic TNBC orthotopic murine models for the development of advanced therapeutics: an immunodeficient human MDA‐MB‐231‐Luc model and an immunocompetent mouse 4T1 model. Furthermore, we provide a broad range of multifactorial analysis for both models that could provide relevant information for the development of new therapies and diagnostic tools. Our comparisons uncovered differential growth rates, stromal arrangements and metabolic profiles in primary tumors, and the presence of cancer‐associated adipocyte infiltration in the MDA‐MB‐231‐Luc model. Histopathological studies highlighted the more rapid metastatic spread to the lungs in the 4T1 model following a lymphatic route, while we observed both homogeneous (MDA‐MB‐231‐Luc) and heterogeneous (4T1) metastatic spread to axillary lymph nodes. We encountered unique metabolomic signatures in each model, including crucial amino acids and cell membrane components. Hematological analysis demonstrated severe leukemoid and lymphoid reactions in the 4T1 model with the partial reestablishment of immune responses in the immunocompromised MDA‐MB‐231‐Luc model. Additionally, we discovered β‐immunoglobulinemia and increased basal levels of G‐CSF correlating with a metastatic switch, with G‐CSF also promoting extramedullary hematopoiesis (both models) and causing hepatosplenomegaly (4T1 model). Overall, we believe that the characterization of these preclinical models will foster the development of advanced therapeutic strategies for TNBC treatment, especially for the treatment of patients presenting both, primary tumors and metastatic spread.</jats:p> |
| container_issue |
8 |
| container_start_page |
2267 |
| container_title |
International Journal of Cancer |
| container_volume |
145 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792345595291107332 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:25:39.144Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Characterization+of+triple%E2%80%90negative+breast+cancer+preclinical+models+provides+functional+evidence+of+metastatic+progression&rft.date=2019-10-15&genre=article&issn=1097-0215&volume=145&issue=8&spage=2267&epage=2281&pages=2267-2281&jtitle=International+Journal+of+Cancer&atitle=Characterization+of+triple%E2%80%90negative+breast+cancer+preclinical+models+provides+functional+evidence+of+metastatic+progression&aulast=Vicent&aufirst=Mar%C3%ADa+J.&rft_id=info%3Adoi%2F10.1002%2Fijc.32270&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792345595291107332 |
| author | Arroyo‐Crespo, Juan J., Armiñán, Ana, Charbonnier, David, Deladriere, Coralie, Palomino‐Schätzlein, Martina, Lamas‐Domingo, Rubén, Forteza, Jerónimo, Pineda‐Lucena, Antonio, Vicent, María J. |
| author_facet | Arroyo‐Crespo, Juan J., Armiñán, Ana, Charbonnier, David, Deladriere, Coralie, Palomino‐Schätzlein, Martina, Lamas‐Domingo, Rubén, Forteza, Jerónimo, Pineda‐Lucena, Antonio, Vicent, María J., Arroyo‐Crespo, Juan J., Armiñán, Ana, Charbonnier, David, Deladriere, Coralie, Palomino‐Schätzlein, Martina, Lamas‐Domingo, Rubén, Forteza, Jerónimo, Pineda‐Lucena, Antonio, Vicent, María J. |
| author_sort | arroyo‐crespo, juan j. |
| container_issue | 8 |
| container_start_page | 2267 |
| container_title | International Journal of Cancer |
| container_volume | 145 |
| description | <jats:p>Triple‐negative breast cancer (TNBC), an aggressive, metastatic and recurrent breast cancer (BC) subtype, currently suffers from a lack of adequately described spontaneously metastatic preclinical models that faithfully reproduce the clinical scenario. We describe two preclinical spontaneously metastatic TNBC orthotopic murine models for the development of advanced therapeutics: an immunodeficient human MDA‐MB‐231‐Luc model and an immunocompetent mouse 4T1 model. Furthermore, we provide a broad range of multifactorial analysis for both models that could provide relevant information for the development of new therapies and diagnostic tools. Our comparisons uncovered differential growth rates, stromal arrangements and metabolic profiles in primary tumors, and the presence of cancer‐associated adipocyte infiltration in the MDA‐MB‐231‐Luc model. Histopathological studies highlighted the more rapid metastatic spread to the lungs in the 4T1 model following a lymphatic route, while we observed both homogeneous (MDA‐MB‐231‐Luc) and heterogeneous (4T1) metastatic spread to axillary lymph nodes. We encountered unique metabolomic signatures in each model, including crucial amino acids and cell membrane components. Hematological analysis demonstrated severe leukemoid and lymphoid reactions in the 4T1 model with the partial reestablishment of immune responses in the immunocompromised MDA‐MB‐231‐Luc model. Additionally, we discovered β‐immunoglobulinemia and increased basal levels of G‐CSF correlating with a metastatic switch, with G‐CSF also promoting extramedullary hematopoiesis (both models) and causing hepatosplenomegaly (4T1 model). Overall, we believe that the characterization of these preclinical models will foster the development of advanced therapeutic strategies for TNBC treatment, especially for the treatment of patients presenting both, primary tumors and metastatic spread.</jats:p> |
| doi_str_mv | 10.1002/ijc.32270 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9pamMuMzIyNzA |
| imprint | Wiley, 2019 |
| imprint_str_mv | Wiley, 2019 |
| institution | DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14 |
| issn | 0020-7136, 1097-0215 |
| issn_str_mv | 0020-7136, 1097-0215 |
| language | English |
| last_indexed | 2024-03-01T17:25:39.144Z |
| match_str | arroyocrespo2019characterizationoftriplenegativebreastcancerpreclinicalmodelsprovidesfunctionalevidenceofmetastaticprogression |
| mega_collection | Wiley (CrossRef) |
| physical | 2267-2281 |
| publishDate | 2019 |
| publishDateSort | 2019 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | International Journal of Cancer |
| source_id | 49 |
| spelling | Arroyo‐Crespo, Juan J. Armiñán, Ana Charbonnier, David Deladriere, Coralie Palomino‐Schätzlein, Martina Lamas‐Domingo, Rubén Forteza, Jerónimo Pineda‐Lucena, Antonio Vicent, María J. 0020-7136 1097-0215 Wiley Cancer Research Oncology http://dx.doi.org/10.1002/ijc.32270 <jats:p>Triple‐negative breast cancer (TNBC), an aggressive, metastatic and recurrent breast cancer (BC) subtype, currently suffers from a lack of adequately described spontaneously metastatic preclinical models that faithfully reproduce the clinical scenario. We describe two preclinical spontaneously metastatic TNBC orthotopic murine models for the development of advanced therapeutics: an immunodeficient human MDA‐MB‐231‐Luc model and an immunocompetent mouse 4T1 model. Furthermore, we provide a broad range of multifactorial analysis for both models that could provide relevant information for the development of new therapies and diagnostic tools. Our comparisons uncovered differential growth rates, stromal arrangements and metabolic profiles in primary tumors, and the presence of cancer‐associated adipocyte infiltration in the MDA‐MB‐231‐Luc model. Histopathological studies highlighted the more rapid metastatic spread to the lungs in the 4T1 model following a lymphatic route, while we observed both homogeneous (MDA‐MB‐231‐Luc) and heterogeneous (4T1) metastatic spread to axillary lymph nodes. We encountered unique metabolomic signatures in each model, including crucial amino acids and cell membrane components. Hematological analysis demonstrated severe leukemoid and lymphoid reactions in the 4T1 model with the partial reestablishment of immune responses in the immunocompromised MDA‐MB‐231‐Luc model. Additionally, we discovered β‐immunoglobulinemia and increased basal levels of G‐CSF correlating with a metastatic switch, with G‐CSF also promoting extramedullary hematopoiesis (both models) and causing hepatosplenomegaly (4T1 model). Overall, we believe that the characterization of these preclinical models will foster the development of advanced therapeutic strategies for TNBC treatment, especially for the treatment of patients presenting both, primary tumors and metastatic spread.</jats:p> Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression International Journal of Cancer |
| spellingShingle | Arroyo‐Crespo, Juan J., Armiñán, Ana, Charbonnier, David, Deladriere, Coralie, Palomino‐Schätzlein, Martina, Lamas‐Domingo, Rubén, Forteza, Jerónimo, Pineda‐Lucena, Antonio, Vicent, María J., International Journal of Cancer, Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression, Cancer Research, Oncology |
| title | Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression |
| title_full | Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression |
| title_fullStr | Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression |
| title_full_unstemmed | Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression |
| title_short | Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression |
| title_sort | characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression |
| title_unstemmed | Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression |
| topic | Cancer Research, Oncology |
| url | http://dx.doi.org/10.1002/ijc.32270 |